InterMune Sets New 1-Year High at $73.25 (ITMN)
Shares of InterMune (NASDAQ:ITMN) reached a new 52-week high during trading on Wednesday , American Banking News reports. The company traded as high as $73.25 and last traded at $73.13, with a volume of 8,180,324 shares. The stock had previously closed at $72.98.
A number of research firms have recently commented on ITMN. Analysts at JMP Securities downgraded shares of InterMune from an “outperform” rating to a “market perform” rating in a research note on Tuesday. Separately, analysts at JPMorgan Chase & Co. downgraded shares of InterMune from an “overweight” rating to a “neutral” rating in a research note on Tuesday. They now have a $74.00 price target on the stock. Finally, analysts at Jefferies Group upgraded shares of InterMune from an “underperform” rating to a “hold” rating in a research note on Monday. They now have a $74.00 price target on the stock, up previously from $25.00. Eight equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $57.91.
The stock’s 50-day moving average is $47.46 and its 200-day moving average is $37.37. The company’s market cap is $7.896 billion. InterMune also was the recipient of some unusual options trading activity on Monday. Stock traders bought 5,253 call options on the stock. This is an increase of 156% compared to the typical daily volume of 2,052 call options.
InterMune (NASDAQ:ITMN) last issued its quarterly earnings data on Wednesday, August 6th. The company reported ($0.72) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.56) by $0.16. The company had revenue of $35.70 million for the quarter, compared to the consensus estimate of $33.96 million. During the same quarter in the prior year, the company posted ($0.77) earnings per share. The company’s quarterly revenue was up 141.2% on a year-over-year basis. Analysts expect that InterMune will post $-2.75 EPS for the current fiscal year.
In other InterMune news, EVP Paul D. Arata unloaded 7,500 shares of InterMune stock on the open market in a transaction dated Wednesday, August 13th. The stock was sold at an average price of $50.00, for a total value of $375,000.00. The sale was disclosed in a document filed with the SEC, which is available at this link.
InterMune, Inc (NASDAQ:ITMN) is a biotechnology company focused on the research, development and commercialization of therapies in pulmonology and orphan fibrotic diseases.
Receive News & Ratings for InterMune Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InterMune Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.